BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sami E, Paul BT, Koziol JA, ElShamy WM. The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages. Cancer Res 2020;80:1102-17. [PMID: 31911557 DOI: 10.1158/0008-5472.CAN-19-2374] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Malla R, Padmaraju V, Kundrapu DB. Tumor-associated macrophages: Potential target of natural compounds for management of breast cancer. Life Sci 2022;301:120572. [PMID: 35489567 DOI: 10.1016/j.lfs.2022.120572] [Reference Citation Analysis]
2 Cruz-Bermúdez A, Laza-Briviesca R, Casarrubios M, Sierra-Rodero B, Provencio M. The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy. Biomedicines 2021;9:361. [PMID: 33807260 DOI: 10.3390/biomedicines9040361] [Reference Citation Analysis]
3 Zhang H, Qin G, Yu H, Han X, Zhu S. Comprehensive genomic and immunophenotypic analysis of CD4 T cell infiltrating human triple-negative breast cancer. Cancer Immunol Immunother 2021;70:1649-65. [PMID: 33301062 DOI: 10.1007/s00262-020-02807-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fan Y, He S. The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer. Cancer Manag Res 2022;14:1-17. [PMID: 35018117 DOI: 10.2147/CMAR.S316700] [Reference Citation Analysis]
5 Wang Z, Wang C, Lin S, Yu X. Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients. Front Oncol 2021;11:725292. [PMID: 34513703 DOI: 10.3389/fonc.2021.725292] [Reference Citation Analysis]
6 Zheng H, Siddharth S, Parida S, Wu X, Sharma D. Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation. Cancers (Basel) 2021;13:3357. [PMID: 34283088 DOI: 10.3390/cancers13133357] [Reference Citation Analysis]
7 Jesser EA, Brady NJ, Huggins DN, Witschen PM, O'Connor CH, Schwertfeger KL. STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment. Breast Cancer Res 2021;23:104. [PMID: 34743736 DOI: 10.1186/s13058-021-01481-0] [Reference Citation Analysis]
8 Clark CA, Yang ES. Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer. Front Oncol 2021;11:703802. [PMID: 34631532 DOI: 10.3389/fonc.2021.703802] [Reference Citation Analysis]
9 Zhou X, Liu Y, Xiang J, Wang Y, Wang Q, Xia J, Chen Y, Bai Y. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy. Front Immunol 2021;12:665002. [PMID: 34367132 DOI: 10.3389/fimmu.2021.665002] [Reference Citation Analysis]
10 Bai X, Ni J, Beretov J, Graham P, Li Y. Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance. Journal of the National Cancer Center 2021;1:75-87. [DOI: 10.1016/j.jncc.2021.06.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mortezaee K, Majidpoor J. (Im)maturity in Tumor Ecosystem. Front Oncol 2022;11:813897. [DOI: 10.3389/fonc.2021.813897] [Reference Citation Analysis]
12 Zhang M, Liu ZZ, Aoshima K, Cai WL, Sun H, Xu T, Zhang Y, An Y, Chen JF, Chan LH, Aoshima A, Lang SM, Tang Z, Che X, Li Y, Rutter SJ, Bossuyt V, Chen X, Morrow JS, Pusztai L, Rimm DL, Yin M, Yan Q. CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression. Sci Transl Med 2022;14:eabf5473. [PMID: 35108062 DOI: 10.1126/scitranslmed.abf5473] [Reference Citation Analysis]
13 Moradpoor R, Salimi M. Crosstalk between Tumor Cells and Immune System Leads to Epithelial-Mesenchymal Transition Induction and Breast Cancer Progression. Iran Biomed J 2021;25:1-7. [PMID: 33129234 DOI: 10.29252/ibj.25.1.1] [Reference Citation Analysis]
14 Qiu X, Zhao T, Luo R, Qiu R, Li Z. Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer. Front Oncol 2022;12:772615. [DOI: 10.3389/fonc.2022.772615] [Reference Citation Analysis]
15 Farina AR, Cappabianca L, Sebastiano M, Zelli V, Guadagni S, Mackay AR. Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer. J Exp Clin Cancer Res. 2020;39:110. [PMID: 32536347 DOI: 10.1186/s13046-020-01616-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
16 Hu S, Qu X, Jiao Y, Hu J, Wang B. Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer. Front Genet 2021;12:710534. [PMID: 34795691 DOI: 10.3389/fgene.2021.710534] [Reference Citation Analysis]